SCHEMBL24587372

SCHEMBL24587372

CCOc1cc(C(C)C)c(Cl)cn1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 2/20 0.37
GABRB1 P18505 2/20 0.37
GABRP O00591 1/20 0.37
GABRD O14764 1/20 0.37
GABRG2 P18507 1/20 0.37
GABRB3 P28472 1/20 0.37
GABRA5 P31644 1/20 0.37
GABRA3 P34903 1/20 0.37
GABRA2 P47869 1/20 0.37
GABRB2 P47870 1/20 0.37
GABRA4 P48169 1/20 0.37
GABRE P78334 1/20 0.37
GABRA6 Q16445 1/20 0.37
GABRG1 Q8N1C3 1/20 0.37
GABRG3 Q99928 1/20 0.37
GABRQ Q9UN88 1/20 0.37
MAPT P10636 1/20 0.35
KRAS P01116 2/20 0.34
SOS1 Q07889 2/20 0.34
PTGES O14684 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14134348 0.83 P2RX3 (0.38) GABRA1GABRB1GABRPGABRDGABRG2
SCHEMBL170307 0.80 GABRA1 (0.41) GABRA1GABRB1GABRPGABRDGABRG2
SCHEMBL23083124 0.79 ALDH1A1 (0.39) GABRA1GABRB1GABRPGABRDGABRG2
SCHEMBL24045130 0.78 KRAS (0.38) GABRA1GABRB1GABRPGABRDGABRG2
SCHEMBL172311 0.77 AOC3 (0.40) GABRA1GABRB1GABRPGABRDGABRG2
SCHEMBL13765680 0.77 GABRP (0.39) GABRA1GABRB1GABRPGABRDGABRG2
SCHEMBL11641291 0.76 MAPT (0.40) GABRA1GABRB1GABRPGABRDGABRG2
SCHEMBL20642297 0.76 LMNA (0.32) GABRA1GABRB1THRATHRBP2RX3
SCHEMBL2737360 0.74 GABRA1 (0.37) GABRA1GABRB1P2RX3P2RX2LMNA
SCHEMBL17494708 0.73 MAPT (0.38) GABRA1GABRB1GABRPGABRDGABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022140169-A1 PREPARATION OF TETRAHYDROINDAZOLE DERIVATIVES AS NOVEL DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2022-06-30 WO disclosed